nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—SLCO1B3—Mycophenolate mofetil—systemic scleroderma	0.236	0.341	CbGbCtD
Olmesartan—SLCO1B1—Mycophenolate mofetil—systemic scleroderma	0.137	0.198	CbGbCtD
Olmesartan—ABCC2—Mycophenolate mofetil—systemic scleroderma	0.121	0.174	CbGbCtD
Olmesartan—SLCO1B3—Methotrexate—systemic scleroderma	0.0945	0.137	CbGbCtD
Olmesartan—SLCO1B1—Methotrexate—systemic scleroderma	0.055	0.0796	CbGbCtD
Olmesartan—ABCC2—Methotrexate—systemic scleroderma	0.0484	0.07	CbGbCtD
Olmesartan—AGTR1—artery—systemic scleroderma	0.0038	0.201	CbGeAlD
Olmesartan—AGTR1—endothelium—systemic scleroderma	0.00321	0.169	CbGeAlD
Olmesartan—AGTR1—blood vessel—systemic scleroderma	0.00296	0.156	CbGeAlD
Olmesartan—AGTR1—connective tissue—systemic scleroderma	0.00152	0.0801	CbGeAlD
Olmesartan—SLCO1B3—lung—systemic scleroderma	0.00151	0.0797	CbGeAlD
Olmesartan—AGTR1—smooth muscle tissue—systemic scleroderma	0.00139	0.0733	CbGeAlD
Olmesartan—SLCO1B1—digestive system—systemic scleroderma	0.00104	0.0552	CbGeAlD
Olmesartan—AGTR1—tendon—systemic scleroderma	0.00104	0.0551	CbGeAlD
Olmesartan—AGTR1—lung—systemic scleroderma	0.000914	0.0483	CbGeAlD
Olmesartan—ABCC2—digestive system—systemic scleroderma	0.000791	0.0418	CbGeAlD
Olmesartan—ABCC2—tendon—systemic scleroderma	0.000753	0.0398	CbGeAlD
Olmesartan—Losartan—ACE—systemic scleroderma	0.00052	1	CrCbGaD
Olmesartan—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000224	0.000775	CcSEcCtD
Olmesartan—Oedema—Lisinopril—systemic scleroderma	0.000224	0.000775	CcSEcCtD
Olmesartan—Pruritus—Captopril—systemic scleroderma	0.000224	0.000775	CcSEcCtD
Olmesartan—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000223	0.000772	CcSEcCtD
Olmesartan—Pain—Leflunomide—systemic scleroderma	0.000223	0.000772	CcSEcCtD
Olmesartan—Constipation—Leflunomide—systemic scleroderma	0.000223	0.000772	CcSEcCtD
Olmesartan—Infection—Lisinopril—systemic scleroderma	0.000223	0.00077	CcSEcCtD
Olmesartan—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000222	0.000769	CcSEcCtD
Olmesartan—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000221	0.000765	CcSEcCtD
Olmesartan—Shock—Lisinopril—systemic scleroderma	0.000221	0.000763	CcSEcCtD
Olmesartan—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00022	0.000761	CcSEcCtD
Olmesartan—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000219	0.000759	CcSEcCtD
Olmesartan—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000219	0.000758	CcSEcCtD
Olmesartan—Neutropenia—Prednisone—systemic scleroderma	0.000219	0.000757	CcSEcCtD
Olmesartan—Tachycardia—Lisinopril—systemic scleroderma	0.000219	0.000757	CcSEcCtD
Olmesartan—Body temperature increased—Azathioprine—systemic scleroderma	0.000218	0.000755	CcSEcCtD
Olmesartan—Abdominal pain—Azathioprine—systemic scleroderma	0.000218	0.000755	CcSEcCtD
Olmesartan—Skin disorder—Lisinopril—systemic scleroderma	0.000218	0.000753	CcSEcCtD
Olmesartan—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000217	0.000751	CcSEcCtD
Olmesartan—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000217	0.00075	CcSEcCtD
Olmesartan—Diarrhoea—Captopril—systemic scleroderma	0.000217	0.000749	CcSEcCtD
Olmesartan—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000216	0.000748	CcSEcCtD
Olmesartan—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000216	0.000748	CcSEcCtD
Olmesartan—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000216	0.000746	CcSEcCtD
Olmesartan—Erectile dysfunction—Prednisone—systemic scleroderma	0.000216	0.000746	CcSEcCtD
Olmesartan—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000215	0.000745	CcSEcCtD
Olmesartan—Feeling abnormal—Leflunomide—systemic scleroderma	0.000215	0.000744	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000215	0.000743	CcSEcCtD
Olmesartan—Fatigue—Mycophenolic acid—systemic scleroderma	0.000215	0.000742	CcSEcCtD
Olmesartan—Nausea—Mometasone—systemic scleroderma	0.000214	0.00074	CcSEcCtD
Olmesartan—Anorexia—Lisinopril—systemic scleroderma	0.000214	0.000739	CcSEcCtD
Olmesartan—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000213	0.000738	CcSEcCtD
Olmesartan—Pain—Mycophenolic acid—systemic scleroderma	0.000213	0.000736	CcSEcCtD
Olmesartan—Constipation—Mycophenolic acid—systemic scleroderma	0.000213	0.000736	CcSEcCtD
Olmesartan—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000213	0.000736	CcSEcCtD
Olmesartan—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000212	0.000732	CcSEcCtD
Olmesartan—Hyperglycaemia—Prednisone—systemic scleroderma	0.000211	0.00073	CcSEcCtD
Olmesartan—Cough—Mycophenolate mofetil—systemic scleroderma	0.00021	0.000726	CcSEcCtD
Olmesartan—Hypotension—Lisinopril—systemic scleroderma	0.000209	0.000725	CcSEcCtD
Olmesartan—Dizziness—Captopril—systemic scleroderma	0.000209	0.000724	CcSEcCtD
Olmesartan—Urticaria—Leflunomide—systemic scleroderma	0.000207	0.000717	CcSEcCtD
Olmesartan—Body temperature increased—Leflunomide—systemic scleroderma	0.000206	0.000713	CcSEcCtD
Olmesartan—Abdominal pain—Leflunomide—systemic scleroderma	0.000206	0.000713	CcSEcCtD
Olmesartan—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000205	0.000709	CcSEcCtD
Olmesartan—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000205	0.000709	CcSEcCtD
Olmesartan—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000205	0.000709	CcSEcCtD
Olmesartan—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000205	0.000709	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000204	0.000706	CcSEcCtD
Olmesartan—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000204	0.000706	CcSEcCtD
Olmesartan—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000204	0.000705	CcSEcCtD
Olmesartan—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000204	0.000704	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000203	0.000704	CcSEcCtD
Olmesartan—Insomnia—Lisinopril—systemic scleroderma	0.000203	0.000701	CcSEcCtD
Olmesartan—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000202	0.0007	CcSEcCtD
Olmesartan—Vomiting—Captopril—systemic scleroderma	0.000201	0.000696	CcSEcCtD
Olmesartan—Rash—Captopril—systemic scleroderma	0.0002	0.00069	CcSEcCtD
Olmesartan—Dermatitis—Captopril—systemic scleroderma	0.000199	0.00069	CcSEcCtD
Olmesartan—Headache—Captopril—systemic scleroderma	0.000198	0.000686	CcSEcCtD
Olmesartan—Dyspepsia—Lisinopril—systemic scleroderma	0.000197	0.000683	CcSEcCtD
Olmesartan—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000197	0.00068	CcSEcCtD
Olmesartan—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000197	0.00068	CcSEcCtD
Olmesartan—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000196	0.000679	CcSEcCtD
Olmesartan—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000196	0.000679	CcSEcCtD
Olmesartan—Infection—Mycophenolate mofetil—systemic scleroderma	0.000195	0.000675	CcSEcCtD
Olmesartan—Decreased appetite—Lisinopril—systemic scleroderma	0.000195	0.000674	CcSEcCtD
Olmesartan—Eosinophilia—Methotrexate—systemic scleroderma	0.000194	0.00067	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000194	0.000669	CcSEcCtD
Olmesartan—Fatigue—Lisinopril—systemic scleroderma	0.000193	0.000668	CcSEcCtD
Olmesartan—Shock—Mycophenolate mofetil—systemic scleroderma	0.000193	0.000668	CcSEcCtD
Olmesartan—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000193	0.000666	CcSEcCtD
Olmesartan—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000192	0.000665	CcSEcCtD
Olmesartan—Pancreatitis—Methotrexate—systemic scleroderma	0.000192	0.000664	CcSEcCtD
Olmesartan—Constipation—Lisinopril—systemic scleroderma	0.000192	0.000663	CcSEcCtD
Olmesartan—Pain—Lisinopril—systemic scleroderma	0.000192	0.000663	CcSEcCtD
Olmesartan—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000192	0.000663	CcSEcCtD
Olmesartan—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000191	0.00066	CcSEcCtD
Olmesartan—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00019	0.000657	CcSEcCtD
Olmesartan—Diarrhoea—Azathioprine—systemic scleroderma	0.000189	0.000654	CcSEcCtD
Olmesartan—Nausea—Captopril—systemic scleroderma	0.000188	0.00065	CcSEcCtD
Olmesartan—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000187	0.000648	CcSEcCtD
Olmesartan—Asthenia—Leflunomide—systemic scleroderma	0.000187	0.000647	CcSEcCtD
Olmesartan—Pancytopenia—Methotrexate—systemic scleroderma	0.000186	0.000643	CcSEcCtD
Olmesartan—Feeling abnormal—Lisinopril—systemic scleroderma	0.000185	0.000639	CcSEcCtD
Olmesartan—Pruritus—Leflunomide—systemic scleroderma	0.000185	0.000638	CcSEcCtD
Olmesartan—Connective tissue disorder—Prednisone—systemic scleroderma	0.000184	0.000637	CcSEcCtD
Olmesartan—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000184	0.000635	CcSEcCtD
Olmesartan—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000183	0.000634	CcSEcCtD
Olmesartan—Neutropenia—Methotrexate—systemic scleroderma	0.000183	0.000633	CcSEcCtD
Olmesartan—Dizziness—Azathioprine—systemic scleroderma	0.000183	0.000632	CcSEcCtD
Olmesartan—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000182	0.000629	CcSEcCtD
Olmesartan—Erectile dysfunction—Methotrexate—systemic scleroderma	0.00018	0.000623	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000179	0.000619	CcSEcCtD
Olmesartan—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000179	0.000618	CcSEcCtD
Olmesartan—Asthenia—Mycophenolic acid—systemic scleroderma	0.000179	0.000618	CcSEcCtD
Olmesartan—Diarrhoea—Leflunomide—systemic scleroderma	0.000179	0.000617	CcSEcCtD
Olmesartan—Urticaria—Lisinopril—systemic scleroderma	0.000178	0.000616	CcSEcCtD
Olmesartan—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000178	0.000614	CcSEcCtD
Olmesartan—Body temperature increased—Lisinopril—systemic scleroderma	0.000177	0.000613	CcSEcCtD
Olmesartan—Abdominal pain—Lisinopril—systemic scleroderma	0.000177	0.000613	CcSEcCtD
Olmesartan—Pruritus—Mycophenolic acid—systemic scleroderma	0.000176	0.000609	CcSEcCtD
Olmesartan—Vomiting—Azathioprine—systemic scleroderma	0.000176	0.000608	CcSEcCtD
Olmesartan—Pneumonia—Methotrexate—systemic scleroderma	0.000175	0.000607	CcSEcCtD
Olmesartan—Infestation NOS—Methotrexate—systemic scleroderma	0.000174	0.000603	CcSEcCtD
Olmesartan—Infestation—Methotrexate—systemic scleroderma	0.000174	0.000603	CcSEcCtD
Olmesartan—Rash—Azathioprine—systemic scleroderma	0.000174	0.000602	CcSEcCtD
Olmesartan—Dermatitis—Azathioprine—systemic scleroderma	0.000174	0.000602	CcSEcCtD
Olmesartan—Headache—Azathioprine—systemic scleroderma	0.000173	0.000599	CcSEcCtD
Olmesartan—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000173	0.000598	CcSEcCtD
Olmesartan—Dizziness—Leflunomide—systemic scleroderma	0.000173	0.000597	CcSEcCtD
Olmesartan—Renal failure—Methotrexate—systemic scleroderma	0.000172	0.000593	CcSEcCtD
Olmesartan—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000171	0.000591	CcSEcCtD
Olmesartan—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00017	0.000589	CcSEcCtD
Olmesartan—Angiopathy—Prednisone—systemic scleroderma	0.00017	0.000588	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00017	0.000587	CcSEcCtD
Olmesartan—Pain—Mycophenolate mofetil—systemic scleroderma	0.000168	0.000581	CcSEcCtD
Olmesartan—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000168	0.000581	CcSEcCtD
Olmesartan—Arrhythmia—Prednisone—systemic scleroderma	0.000167	0.000579	CcSEcCtD
Olmesartan—Haematuria—Methotrexate—systemic scleroderma	0.000166	0.000575	CcSEcCtD
Olmesartan—Vomiting—Leflunomide—systemic scleroderma	0.000166	0.000574	CcSEcCtD
Olmesartan—Alopecia—Prednisone—systemic scleroderma	0.000166	0.000573	CcSEcCtD
Olmesartan—Dizziness—Mycophenolic acid—systemic scleroderma	0.000165	0.000569	CcSEcCtD
Olmesartan—Rash—Leflunomide—systemic scleroderma	0.000164	0.000569	CcSEcCtD
Olmesartan—Dermatitis—Leflunomide—systemic scleroderma	0.000164	0.000568	CcSEcCtD
Olmesartan—Mental disorder—Prednisone—systemic scleroderma	0.000164	0.000568	CcSEcCtD
Olmesartan—Nausea—Azathioprine—systemic scleroderma	0.000164	0.000568	CcSEcCtD
Olmesartan—Headache—Leflunomide—systemic scleroderma	0.000163	0.000565	CcSEcCtD
Olmesartan—Malnutrition—Prednisone—systemic scleroderma	0.000163	0.000564	CcSEcCtD
Olmesartan—Agranulocytosis—Methotrexate—systemic scleroderma	0.000163	0.000563	CcSEcCtD
Olmesartan—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000162	0.00056	CcSEcCtD
Olmesartan—Asthenia—Lisinopril—systemic scleroderma	0.000161	0.000556	CcSEcCtD
Olmesartan—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000161	0.000556	CcSEcCtD
Olmesartan—Pruritus—Lisinopril—systemic scleroderma	0.000159	0.000549	CcSEcCtD
Olmesartan—Vomiting—Mycophenolic acid—systemic scleroderma	0.000158	0.000547	CcSEcCtD
Olmesartan—Rash—Mycophenolic acid—systemic scleroderma	0.000157	0.000543	CcSEcCtD
Olmesartan—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000157	0.000542	CcSEcCtD
Olmesartan—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000156	0.00054	CcSEcCtD
Olmesartan—Headache—Mycophenolic acid—systemic scleroderma	0.000156	0.000539	CcSEcCtD
Olmesartan—Pharyngitis—Methotrexate—systemic scleroderma	0.000155	0.000538	CcSEcCtD
Olmesartan—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000155	0.000537	CcSEcCtD
Olmesartan—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000155	0.000537	CcSEcCtD
Olmesartan—Nausea—Leflunomide—systemic scleroderma	0.000155	0.000536	CcSEcCtD
Olmesartan—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000155	0.000535	CcSEcCtD
Olmesartan—Vision blurred—Prednisone—systemic scleroderma	0.000154	0.000532	CcSEcCtD
Olmesartan—Urethral disorder—Methotrexate—systemic scleroderma	0.000154	0.000531	CcSEcCtD
Olmesartan—Diarrhoea—Lisinopril—systemic scleroderma	0.000153	0.000531	CcSEcCtD
Olmesartan—Ill-defined disorder—Prednisone—systemic scleroderma	0.000151	0.000524	CcSEcCtD
Olmesartan—Anaemia—Prednisone—systemic scleroderma	0.000151	0.000522	CcSEcCtD
Olmesartan—Agitation—Prednisone—systemic scleroderma	0.00015	0.000519	CcSEcCtD
Olmesartan—Angioedema—Prednisone—systemic scleroderma	0.000149	0.000516	CcSEcCtD
Olmesartan—Dizziness—Lisinopril—systemic scleroderma	0.000148	0.000513	CcSEcCtD
Olmesartan—Nausea—Mycophenolic acid—systemic scleroderma	0.000148	0.000511	CcSEcCtD
Olmesartan—Malaise—Prednisone—systemic scleroderma	0.000147	0.000509	CcSEcCtD
Olmesartan—Vertigo—Prednisone—systemic scleroderma	0.000147	0.000507	CcSEcCtD
Olmesartan—Syncope—Prednisone—systemic scleroderma	0.000146	0.000506	CcSEcCtD
Olmesartan—Loss of consciousness—Prednisone—systemic scleroderma	0.000143	0.000496	CcSEcCtD
Olmesartan—Vomiting—Lisinopril—systemic scleroderma	0.000143	0.000493	CcSEcCtD
Olmesartan—Angiopathy—Methotrexate—systemic scleroderma	0.000142	0.000491	CcSEcCtD
Olmesartan—Rash—Lisinopril—systemic scleroderma	0.000141	0.000489	CcSEcCtD
Olmesartan—Dermatitis—Lisinopril—systemic scleroderma	0.000141	0.000488	CcSEcCtD
Olmesartan—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000141	0.000488	CcSEcCtD
Olmesartan—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000141	0.000487	CcSEcCtD
Olmesartan—Headache—Lisinopril—systemic scleroderma	0.00014	0.000486	CcSEcCtD
Olmesartan—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000139	0.000481	CcSEcCtD
Olmesartan—Arthralgia—Prednisone—systemic scleroderma	0.000139	0.00048	CcSEcCtD
Olmesartan—Myalgia—Prednisone—systemic scleroderma	0.000139	0.00048	CcSEcCtD
Olmesartan—Anxiety—Prednisone—systemic scleroderma	0.000138	0.000479	CcSEcCtD
Olmesartan—Alopecia—Methotrexate—systemic scleroderma	0.000138	0.000479	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000138	0.000477	CcSEcCtD
Olmesartan—Discomfort—Prednisone—systemic scleroderma	0.000137	0.000475	CcSEcCtD
Olmesartan—Mental disorder—Methotrexate—systemic scleroderma	0.000137	0.000475	CcSEcCtD
Olmesartan—Malnutrition—Methotrexate—systemic scleroderma	0.000136	0.000472	CcSEcCtD
Olmesartan—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000134	0.000465	CcSEcCtD
Olmesartan—Nausea—Lisinopril—systemic scleroderma	0.000133	0.000461	CcSEcCtD
Olmesartan—Oedema—Prednisone—systemic scleroderma	0.000133	0.00046	CcSEcCtD
Olmesartan—Anaphylactic shock—Prednisone—systemic scleroderma	0.000133	0.00046	CcSEcCtD
Olmesartan—Infection—Prednisone—systemic scleroderma	0.000132	0.000457	CcSEcCtD
Olmesartan—Back pain—Methotrexate—systemic scleroderma	0.000132	0.000456	CcSEcCtD
Olmesartan—Shock—Prednisone—systemic scleroderma	0.000131	0.000453	CcSEcCtD
Olmesartan—Nervous system disorder—Prednisone—systemic scleroderma	0.000131	0.000452	CcSEcCtD
Olmesartan—Tachycardia—Prednisone—systemic scleroderma	0.00013	0.000449	CcSEcCtD
Olmesartan—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00013	0.000449	CcSEcCtD
Olmesartan—Skin disorder—Prednisone—systemic scleroderma	0.000129	0.000447	CcSEcCtD
Olmesartan—Hyperhidrosis—Prednisone—systemic scleroderma	0.000129	0.000445	CcSEcCtD
Olmesartan—Vision blurred—Methotrexate—systemic scleroderma	0.000128	0.000444	CcSEcCtD
Olmesartan—Anorexia—Prednisone—systemic scleroderma	0.000127	0.000439	CcSEcCtD
Olmesartan—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000127	0.000438	CcSEcCtD
Olmesartan—Anaemia—Methotrexate—systemic scleroderma	0.000126	0.000436	CcSEcCtD
Olmesartan—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000125	0.000432	CcSEcCtD
Olmesartan—Rash—Mycophenolate mofetil—systemic scleroderma	0.000124	0.000428	CcSEcCtD
Olmesartan—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000124	0.000428	CcSEcCtD
Olmesartan—Headache—Mycophenolate mofetil—systemic scleroderma	0.000123	0.000426	CcSEcCtD
Olmesartan—Malaise—Methotrexate—systemic scleroderma	0.000123	0.000425	CcSEcCtD
Olmesartan—Vertigo—Methotrexate—systemic scleroderma	0.000122	0.000424	CcSEcCtD
Olmesartan—Leukopenia—Methotrexate—systemic scleroderma	0.000122	0.000422	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000121	0.00042	CcSEcCtD
Olmesartan—Insomnia—Prednisone—systemic scleroderma	0.00012	0.000416	CcSEcCtD
Olmesartan—Cough—Methotrexate—systemic scleroderma	0.000119	0.000411	CcSEcCtD
Olmesartan—Dyspepsia—Prednisone—systemic scleroderma	0.000117	0.000405	CcSEcCtD
Olmesartan—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000117	0.000404	CcSEcCtD
Olmesartan—Arthralgia—Methotrexate—systemic scleroderma	0.000116	0.000401	CcSEcCtD
Olmesartan—Chest pain—Methotrexate—systemic scleroderma	0.000116	0.000401	CcSEcCtD
Olmesartan—Myalgia—Methotrexate—systemic scleroderma	0.000116	0.000401	CcSEcCtD
Olmesartan—Decreased appetite—Prednisone—systemic scleroderma	0.000116	0.0004	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000115	0.000399	CcSEcCtD
Olmesartan—Fatigue—Prednisone—systemic scleroderma	0.000115	0.000397	CcSEcCtD
Olmesartan—Discomfort—Methotrexate—systemic scleroderma	0.000115	0.000397	CcSEcCtD
Olmesartan—Constipation—Prednisone—systemic scleroderma	0.000114	0.000394	CcSEcCtD
Olmesartan—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000111	0.000385	CcSEcCtD
Olmesartan—Infection—Methotrexate—systemic scleroderma	0.000111	0.000382	CcSEcCtD
Olmesartan—Feeling abnormal—Prednisone—systemic scleroderma	0.00011	0.000379	CcSEcCtD
Olmesartan—Nervous system disorder—Methotrexate—systemic scleroderma	0.000109	0.000377	CcSEcCtD
Olmesartan—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000109	0.000377	CcSEcCtD
Olmesartan—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000109	0.000377	CcSEcCtD
Olmesartan—Skin disorder—Methotrexate—systemic scleroderma	0.000108	0.000374	CcSEcCtD
Olmesartan—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000108	0.000372	CcSEcCtD
Olmesartan—Anorexia—Methotrexate—systemic scleroderma	0.000106	0.000367	CcSEcCtD
Olmesartan—Urticaria—Prednisone—systemic scleroderma	0.000106	0.000366	CcSEcCtD
Olmesartan—Abdominal pain—Prednisone—systemic scleroderma	0.000105	0.000364	CcSEcCtD
Olmesartan—Body temperature increased—Prednisone—systemic scleroderma	0.000105	0.000364	CcSEcCtD
Olmesartan—Hypotension—Methotrexate—systemic scleroderma	0.000104	0.00036	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000101	0.000351	CcSEcCtD
Olmesartan—Insomnia—Methotrexate—systemic scleroderma	0.000101	0.000348	CcSEcCtD
Olmesartan—Dyspepsia—Methotrexate—systemic scleroderma	9.79e-05	0.000339	CcSEcCtD
Olmesartan—Decreased appetite—Methotrexate—systemic scleroderma	9.67e-05	0.000335	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Methotrexate—systemic scleroderma	9.61e-05	0.000332	CcSEcCtD
Olmesartan—Fatigue—Methotrexate—systemic scleroderma	9.59e-05	0.000332	CcSEcCtD
Olmesartan—Asthenia—Prednisone—systemic scleroderma	9.55e-05	0.00033	CcSEcCtD
Olmesartan—Pain—Methotrexate—systemic scleroderma	9.52e-05	0.000329	CcSEcCtD
Olmesartan—Pruritus—Prednisone—systemic scleroderma	9.42e-05	0.000326	CcSEcCtD
Olmesartan—Feeling abnormal—Methotrexate—systemic scleroderma	9.17e-05	0.000317	CcSEcCtD
Olmesartan—Diarrhoea—Prednisone—systemic scleroderma	9.11e-05	0.000315	CcSEcCtD
Olmesartan—Gastrointestinal pain—Methotrexate—systemic scleroderma	9.1e-05	0.000315	CcSEcCtD
Olmesartan—Urticaria—Methotrexate—systemic scleroderma	8.84e-05	0.000306	CcSEcCtD
Olmesartan—Dizziness—Prednisone—systemic scleroderma	8.8e-05	0.000305	CcSEcCtD
Olmesartan—Abdominal pain—Methotrexate—systemic scleroderma	8.8e-05	0.000304	CcSEcCtD
Olmesartan—Body temperature increased—Methotrexate—systemic scleroderma	8.8e-05	0.000304	CcSEcCtD
Olmesartan—Vomiting—Prednisone—systemic scleroderma	8.47e-05	0.000293	CcSEcCtD
Olmesartan—Rash—Prednisone—systemic scleroderma	8.39e-05	0.00029	CcSEcCtD
Olmesartan—Dermatitis—Prednisone—systemic scleroderma	8.39e-05	0.00029	CcSEcCtD
Olmesartan—Headache—Prednisone—systemic scleroderma	8.34e-05	0.000288	CcSEcCtD
Olmesartan—Asthenia—Methotrexate—systemic scleroderma	7.98e-05	0.000276	CcSEcCtD
Olmesartan—Nausea—Prednisone—systemic scleroderma	7.91e-05	0.000274	CcSEcCtD
Olmesartan—Pruritus—Methotrexate—systemic scleroderma	7.87e-05	0.000272	CcSEcCtD
Olmesartan—Diarrhoea—Methotrexate—systemic scleroderma	7.61e-05	0.000263	CcSEcCtD
Olmesartan—Dizziness—Methotrexate—systemic scleroderma	7.36e-05	0.000254	CcSEcCtD
Olmesartan—Vomiting—Methotrexate—systemic scleroderma	7.07e-05	0.000245	CcSEcCtD
Olmesartan—Rash—Methotrexate—systemic scleroderma	7.02e-05	0.000243	CcSEcCtD
Olmesartan—Dermatitis—Methotrexate—systemic scleroderma	7.01e-05	0.000242	CcSEcCtD
Olmesartan—Headache—Methotrexate—systemic scleroderma	6.97e-05	0.000241	CcSEcCtD
Olmesartan—Nausea—Methotrexate—systemic scleroderma	6.61e-05	0.000229	CcSEcCtD
